R
Raymond R. Townsend
Researcher at University of Pennsylvania
Publications - 706
Citations - 47086
Raymond R. Townsend is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Blood pressure & Kidney disease. The author has an hindex of 84, co-authored 673 publications receiving 39096 citations. Previous affiliations of Raymond R. Townsend include University of Texas Medical Branch & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Muscle Cramps and Diuretic Therapy
Ari Mosenkis,Raymond R. Townsend +1 more
TL;DR: It is likely that cramps that occur in the course of diuretic therapy are attributed to electrolyte disturbances or volume contraction, and are treated accordingly, but not with quinine, according to a review of the Physicians’ Desk Reference database.
Journal ArticleDOI
Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease.
Rupal Mehta,Rupal Mehta,Monique E. Cho,Xuan Cai,Jongmin Lee,Jing Chen,Jiang He,John M. Flack,Tariq Shafi,Santosh L. Saraf,Valentin David,Harold I. Feldman,Tamara Isakova,Myles Wolf,Lawrence J. Appel,Alan S. Go,James P. Lash,Robert G. Nelson,Mahboob Rahman,Panduranga S. Rao,Vallabh O. Shah,Raymond R. Townsend,Mark Unruh +22 more
TL;DR: In this paper, the authors investigated risks of mortality, heart failure, end-stage kidney disease (ESKD), and atherosclerotic cardiovascular disease according to iron status, and tested for mediation by C-terminal fibroblast growth factor 23 (FGF23), hemoglobin and parathyroid hormone.
Journal ArticleDOI
Stroke in chronic kidney disease: prevention and management.
TL;DR: Some physiologic and clinical evidence suggests that angiotensin II receptor blockers may offer superior benefit to that of ang Elliotensin-converting enzyme inhibitors for the same level of blood pressure control; however, few head-to-head trials have compared these two agent classes directly using stroke as an outcome.
Journal ArticleDOI
Living Donor Kidney Donation: Another Form of White Coat Effect
TL;DR: The remarkable differences between clinic SBP and ambulatory SBP prior to donation, and the disappearance of these differences 6 months later, suggest a substantial white coat effect on SBP associated with living kidney donor evaluation and ABPM represents a better way to assess blood pressure prior to kidney donation.
Journal ArticleDOI
Blood pressure effects of naproxcinod in hypertensive patients.
Raymond R. Townsend,Neville Bittar,Jeffrey M. Rosen,William B. Smith,Andrea Ramsay,Steven G. Chrysant,Robert J. Weiss,Aldina Pivodic,Brigitte Duquesroix,Jacques Djian +9 more
TL;DR: Naproxcinod may be a beneficial alternative for patients with osteoarthritis requiring nonsteroidal anti‐inflammatory drugs.